Coverage / ITRMF / Trade Card

ITRMF

Iterum Therapeutics PLC

SPECULATIVE BUY 2026-08-01 Updated today USD 0.00 Healthcare - Biotechnology
42

Position levels

Currenttoday
USD 0.00
Buy <=wait / entry
-
Trim >=take some off
-
Thesis breaknot set
-

Scenario-weighted conviction

ProbabilityScoreContribution
Bull case8%100 / 1008.0
Base case48%62 / 10029.8
Bear case44%10 / 1004.4
Weighted conviction42 / 100 - SPECULATIVE BUY

Top risks

  • Nasdaq delisting of ordinary shares
  • Ongoing quarterly losses with minimal revenue (e.g., 2025Q3 revenue $390K)
  • Narrow asset base dependency
Read full report →

Research is for informational purposes only. Not financial advice. All analysis reflects the date of publication.